C. W. GREWE

Statistics

Publications

Citations

716

H-Index

Active since

1981

Affiliations

National Institute of Neurological Disorders and Stroke(Current)

National Institutes of Health

C. W. GREWE is an author at National Institute of Neurological Disorders and Stroke specializing in adenylate cyclase signaling, adenylate cyclase regulation, and pharmacology.

Publications per year

1981–1984

Publications

Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor

K. Tsuruta, E.A. Frey, C. W. GREWE et al. · Nature · 1981 · 343 citations

Medicine, Neuroscience, Pharmacology +12

Stimulation of a D-2 Dopamine Receptor in the Intermediate Lobe of the Rat Pituitary Gland Decreases the Responsiveness of the β-Adrenoceptor: Biochemical Mechanism

C. W. GREWE, John W. Kebabian · Endocrinology · 1981 · 88 citations

Medicine, Endocrinology, Pharmacology +17

D-2 Dopamine Receptor-Mediated Inhibition of Adenylate Cyclase Activity in the Intermediate Lobe of the Rat Pituitary Gland Requires Guanosine 5'-Triphosphate

C. W. GREWE, K. Tsuruta, J.C. Stoof et al. · Endocrinology · 1982 · 78 citations

Life Sciences, Neurobiology, Pharmacology +17

Actions of growth hormone-releasing factor and somatostatin on adenylate cyclase and growth hormone release in rat anterior pituitary

James P. Harwood, C. W. GREWE, Greti Aguilera · Molecular and Cellular Endocrinology · 1984 · 47 citations

Life Sciences, Endocrinology, Neuroscience +16

[<sup>3</sup>H]Spiroperidol Identifies a D-2 Dopamine Receptor Inhibiting Adenylate Cyclase Activity in the Intermediate Lobe of the Rat Pituitary Gland

E.A. Frey, C. W. GREWE, John W. Kebabian · Endocrinology · 1982 · 46 citations

Medicine, Neurobiology, Pharmacology +17

1–5 of 9